11 PhD positions in the MSCA Doctoral Network MITGEST

11 PhD positions are available in the Marie Sklodowska-Curie Doctoral Network “MITGEST – Quality control of the mitochondrial gene expression system in health and disease”. MITGEST unites world-class academic excellence in mtDNA maintenance and expression with private sector expertise in nucleic acid chemistry and the development of mitochondrial therapeutics. The consortium includes the Institute of Hematology and Transfusion Medicine, Radboud University Medical Center, The Institue of Biochemistry and Biophysics of the Poly Academy of Sciences, Karolinska Institute, Biodonostia Health Research Institute, Baseclick GmbH, Minovia Therapeutics LTD and the University College London.

The 11 MITGEST Doctoral Candidates will be part of an interdisciplinary and international network.


Successful candidates will be part of a international and interdisciplinary network.

  • MITGEST fellows will be employed according to the rules for Doctoral Candidates in MSCA DNs and the general regulations of each host institution.

  • The financial package will include the three monthly researcher allowances: 1) Living allowance of €3,400 (country correction coefficient applies), 2) Mobility allowance of €600, 3) Family allowance (€660), if applicable. Employer costs and other deductions depend on recruiting host.

Eligibility criteria

  • Supported researchers: Applicants must be doctoral candidates,i.e not already in possession of a doctoral degree at the date of recruitment.

  • Mobility rule: researchers must not have resided or carried out their main activity (e.g. work, studies) in the country of the recruiting beneficiary for more than 12 months in the 36 months immediately before their recruitment date.

  • Other eligibility criteria may apply depending on the recruiting beneficiary. Please check the MITGEST website for further details.

Selection process

Our selection procedure is open, transparent, merit-based and in line with the Code of Conduct for the Recruitment of Researchers.

  • Applicants must submit all necessary documents as one single PDF file via email to the provided email address.

  • After the closure of the application deadline, all documents will be reviewed within two weeks.

  • Pre-selected candidates will be invited for the next steps of the application process, including interviews.

  • The host institution will inform the successful candidate(s) within a few weeks after the interview.

The following PhD projects are available:

  • DC1: Molecular mechanisms involved in the degradation processes of damaged mitochondrial messenger RNAs.

  • DC2: Influence of mitochondrial metabolic alteration on mitochondria-nucleus crosstalk: a multi-omics study.

  • DC3: Synthesis, processing and degradation of mitochondrial RNA.

  • DC4: Functional proteomics of the mitochondrial gene expression system.

  • DC5: Identification and functional analysis of new factors and regulatory mechanisms of mitochondrial antisense RNA surveillance.

  • DC6: Quality control mechanisms involved in mitochondrial translation.

  • DC7: The impact of nutrient metabolism on mitochondrial DNA maintenance and expression in health and disease.

  • DC8: Mitochondrial genomic instability and disease.

  • DC9: Targeting of nucleic acid drugs: a new mitochondrial RNA therapeutic strategy.

  • DC10: The functionality of mitochondrial quality control (MQC) mechanisms within mitochondrial DNA diseases.

  • DC11: The effects of manipulating nutrient metabolism and nucleotide supplementation on organ pathophysiology.

For detailed descriptions of each project, please go to the MITGEST website (www.mitgest-eu/open-positions).